Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Servier CDMO
32 Articles Available
0
2
Can't find what you're looking for? Try our
advanced search
.
The Road to 2021
Road to 2021 Day 24: France
PAO-04-22-R221-51
Servier Acquires Symphogen
PR-M04-20-NI-006
Serialization Update
Revisiting the Global Serialization Landscape
PAP-Q2-2019-CL-030
Expansion
Servier Cuts Ribbon on New Boston Headquarters
PR-M05-19-NI-037
DCAT '19
Highly Potent API and Sterile Capabilities Key to DCAT Week ‘19 Company Announcements
PAO-M03-19-NI-024
Collaboration
Amgen, Cytokinetics and Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure
PR-M02-19-NI-052
Global Network
Risk Minimization with an Integrated Global Network
PAP-Q4-18-CL-005
Design Logic
Preparative Chromatography
PAP-Q4-18-NI-002
Chromatography
Accelerating Time to Market with Integrated Preparative Chromatography Support
PAP-Q3-18-CL-010
Announcement
Shire Exec Selected to Run Servier Pharmaceuticals U.S.
PAO-M07-18-NI-015
Regulatory
Reducing Time to Market with Targeted Regulatory Affairs Support
PAO-06-18-CL-003
Corporate Social Responsibility
Corporate Social Responsibility as a Driver for Improved Sustainability
PAP-Q2-18-CL-014
Endpoint
Phase III Study Evaluating the Efficacy and Safety of Lonsurf in Patients with Metastatic Gastric Cancer Meets Primary Endpoint
PR-M05-18-NI-040
Acquisition
Shire Announces Sale of Oncology Business to Servier for $2.4 Billion
PR-M04-18-NI-59
Operational Excellence
Transforming A CDMO Using an Operational Excellence Approach
PAO-M03-18-CL-003
Innovation
WeHealth by Servier and DEEPLINK MEDICAL sign a partnership to develop a new e-health solution
PR-M03-18-NI-059
Industry
Why Business Continuity Management is Important for CDMOs
PAP-Q1-18-CL-003
Servier Reports Year-On-Year Growth
PAO-M02-18-NI-024
Strategic Partnership
ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody
PR-M02-18-NI-64
Symposium
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium
PR-M01-18-NI-080
Partnership
Servier Canada and the New Brunswick Health Research Foundation announce the creation of the Servier-New Brunswick Cardiac Health Improvement Fund (CHIF)
PR-M01-18-NI-058
API
Achieving Efficient Pharmaceutical Synthesis with Process Intensification
PAP-Q4-17-CL-003
CDMO
Servier CDMO Expands Preparative Chromatography Platform At Normandy Site To Support Market Need
PR-M10-17-NI-007
Pharma 2020
Russian Pharma Market Offers Great Potential for Local Manufacturers
PAP-Q3-17-CL-004
«
0
2
»
.svg)
